Dr. Christopher Kenny Templeton Iv is a Edmond, Oklahoma based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 125 E 3rd St Ste A, Edmond. Patients can reach him at 405-216-3735.
Dr. Christopher Kenny Templeton Iv deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Christopher Kenny Templeton Iv speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Christopher Kenny Templeton Iv
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
125 E 3rd St Ste A, Edmond, Oklahoma, 73034-3822
Phone:
405-216-3735
Fax:
405-216-5363
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
4183861024
Enrollment ID:
I20160422000706
NPI Number:
1073622189
NPI Enumeration Date:
30 Aug, 2006
NPI Last Update On:
14 Feb, 2020
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
125 E 3rd St Ste A, Edmond, Oklahoma
Zip:
73034-3822
Phone Number:
405-216-3735
Fax Number:
405-216-5363
Patients can reach Dr. Christopher Kenny Templeton Iv at 125 E 3rd St Ste A, Edmond, Oklahoma or can call to book an appointment on 405-216-3735. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.